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Hypervirulent Klebsiella pneumoniae strains are usually susceptible to many
antimicrobial agents including colistin. Here we report the isolation and characterization
of several colistin-resistant hypervirulent K. pneumoniae clinical strains. K. pneumoniae
strains recovered from blood samples were collected at a university hospital in China.
MICs of colistin were determined using microdilution. Colistin-resistant strains were
subjected to whole genome sequencing to reveal their clonal background, antimicrobial
resistance determinants and virulence factors. Virulence assays were performed with
strains carrying the mucoid phenotype regulator gene rmpA using wax moth larvae.
The pmrB gene encoding a P344L substitution was cloned into a colistin-susceptible
K. pneumoniae strain to examine whether the substitution confers colistin resistance.
Five colistin-resistant hypervirulent K. pneumoniae were recovered from blood samples
of patients in China, belonging to four sequence/capsular types (ST23:K1, ST412:K57,
ST660:K16, and ST700:K1) and carried the virulence factor rmpA. Three strains had the
known colistin-resistant D150G substitution in PhoQ including one ST700:K1 strain also
carrying mcr-1. The remaining two isolates had a P344L substitution of PmrB but cloning
of pmrB encoding the substitution into a colistin-susceptible isolate did not alter MICs
of colistin, suggesting that such a substitution did not confer resistance to colistin. In
conclusion, the convergence of colistin resistance and hypervirulence in K. pneumoniae
of multiple clonal backgrounds has emerged and may warrant further surveillance.
Keywords: colistin resistance, hypervirulence, Klebsiella, plasmid, Mcr-1 colistin resistance
INTRODUCTION
Klebsiella pneumoniae is one of the most common bacterial pathogens isolated from clinical
infections. Certain sequence and capsular types (e.g., ST23:K1) of the organism display the
hypermucoviscous phenotype and carry a number of critical virulence factors such as regulators of
mucoid phenotype (rmpA, rmpA2), aerobactin (iucABCD, iutA), colibactin (clbA-R), salmochelin
(iroN, iroBCD), and yersiniabactin (irp2, ybtAEPQTUX) (Brisse et al., 2009; Holt et al., 2015).
These hypervirulent K. pneumoniae (hvKP) are a particular threat for human health as they are
able to cause severe infections in apparently healthy persons with high mortality (Shon and Russo,
2012). hvKP is commonly susceptible to many antimicrobial agents including carbapenems and
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colistin (Shon and Russo, 2012; Holt et al., 2015). However, some
carbapenem-resistant hvKP strains have been found in China
and belong to the widely distributed sequence type 11 (ST11)
(Zhan et al., 2017; Gu et al., 2018) and several other sequence
types, e.g., ST25 and ST65 (Yao et al., 2015). A recent study
(Gu et al., 2018) has revealed that an ST11 carbapenem-resistant
K. pneumoniae acquired a pLVPK-like virulence plasmid and
therefore became hypervirulent. The combination of carbapenem
resistance and hypervirulence significantly compromises options
of antimicrobial agents for treating the life-threatening infections
caused by these strains and therefore represents a major
urgent challenge for clinical treatment, infection control and
public health (Chen and Kreiswirth, 2018). Colistin is the last
resort agent against carbapenem-resistant K. pneumoniae but
colistin-resistant K. pneumoniae has also emerged worldwide
(Olaitan et al., 2014). The combination of colistin resistance and
hypervirulence will represent another major urgent challenge for
human health. Here we report the isolation and characterization
of five colistin-resistant hvKP clinical strains from different clonal
backgrounds.
MATERIALS AND METHODS
Strains and in vitro Susceptibility
Non-duplicated Klebsiella strains that were recovered from the
blood of patients at West China Hospital, Sichuan University
between December 2015 and July 2016 were collected. Initial
species identification was performed using Vitek II (bioMérieux,
Marcy-l’Étoile, France) and MALDI-TOF (Bruker, Billerica, MA,
United States). The study has been approved by the Ethical
Committee of West China Hospital with inform consent being
waived. In vitro susceptibility tests of amikacin, ceftriaxone,
ciprofloxacin, gentamicin, imipenem, piperacillin-tazobactam,
sulfamethoxazole-trimethoprim, and tigecycline were performed
using Vitek II. MICs of colistin were determined using the broth
microdilution method of the Clinical and Laboratory Standards
Institute (CLSI) (CLSI, 2017) and breakpoints of colistin defined
by EUCAST1 were applied.
String Tests
Colonies of the strains were stretched by an inoculation loop in
the string test as described previously (Shon and Russo, 2012).
The strains that formed viscous strings > 5 mm in length were
considered hypermucoviscous.
Whole Genomic Sequencing and
Analysis
The strains were subjected to whole genomic sequencing
using the HiSeq X10 Sequencer (Illumina, San Diego, CA,
United States) with the 150-bp paired-end protocol and
approximately 300 × coverage. Raw reads were processed
via adapter-trimming (Illumina TruSeq DNA adapter), end-
cropping (10-bp from both ends) and quality-filtering (lower
than Q20) using Trimmomatic (Bolger et al., 2014). Draft
1http://www.eucast.org/
genomes were then assembled using Unicycler (Wick et al., 2017)
in conservative mode with other settings remaining as default,
and were annotated using Prokka (Seemann, 2014). Species
identification was further established by the pair-wise average
nucleotide identity (ANI) between the isolates and type strains
of Klebsiella species using the JSpecies program based on BLAST
(Richter and Rossello-Mora, 2009).
Sequence types of these strains were determined using
the assembled contigs to query the multi-locus sequence
typing database available at http://bigsdb.pasteur.fr/klebsiella/
klebsiella.html, while the capsular typing was performed for
K. pneumoniae strains using Kaptive2. Antimicrobial resistance
genes were predicted using ResFinder at the Center for Genomic
Epidemiology.3 Small insertions and deletions, as well as high
quality SNPs were identified by mapping reads against the draft
genome of KP925 using snippy v4.04 with default settings. Core
SNPs were then used as the input for phylogenetic tree inference
using RAxML (Stamatakis, 2014) with a 1,000-bootstrap test.
Virulence genes were identified using the database available
at http://bigsdb.pasteur.fr/klebsiella/klebsiella.html. The well-
studied 208,166-bp virulence plasmid pLVPK (IncHI1/IncFIB;
GenBank accession no. AY378100) possesses rmpA, rmpA2,
iucABCD, iutA, and iroBCDN and was selected as the reference to
align contigs of the five strains in this study using BRIG (Alikhan
et al., 2011).
Nucleotide Sequence Accession Numbers
Draft whole-genome sequences of the five strains have
been deposited into GenBank under the accession no.
NWCC00000000 (KP209), NWCN00000000 (KP775),
NWDO00000000 (KP543), NWEN00000000 (KP925), and
NWEQ00000000 (KP767).
Cloning of pmrB Encoding a P344L
Substitution
Two strains, KP925 and KP209, had no known chromosomal or
plasmid-borne mechanisms mediating colistin resistance.
However, their pmrB genes, which encode PmrB, part
of the PmrAB two-component system, have a C1031T
mutation encoding a P344L substitution. Whether the P344L
substitution of PmrB could mediate colistin resistance has
not been studied before. We therefore cloned the pmrB gene
encoding the P344L substitution. The 1098-bp pmrB gene
was amplified with self-designed primers XhoI_pmrAB_F
(CCGCTCGAGCGGTCATTACAGCCTGATCGTGCTGGATC
TCG; the restriction site is underlined) and EcoRI_pmrAB_R
(CCGGAATTCCGGTCGTCCTGCTTGCCAGATAACAAACA
TTT) from strain KP925. The wild-type pmrB gene (without
encoding the P344L substitution) and its promoter sequence
was also amplified using the same primers from a colistin-
susceptible K. pneumoniae strain, KP9G2, for control. Both
PCR amplicons and the vector pBC SK (Stratagene, La Jolla,
CA, United States) were digested using XhoI and EcoRI
2github.com/katholt/Kaptive
3http://genomicepidemiology.org/
4https://github.com/tseemann/snippy
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(NEB, Ipswich, MA, United States) and were ligated using
T4 ligase (NEB) to construct pBC SK-pmrBwild (containing
pmrB from KP9G2) and pBC SK-pmrBP344L (containing pmrB
encoding the P344L substitution). pBC SK-pmrBwild and
pBC SK-pmrBP344L were transformed into KP9G2, KP925,
and KP209 by electroporation. Transformants were selected
on agar plates containing 35 µg/ml chloramphenicol and
pmrB sequences on the clonal vector in transformants were
obtained using PCR with primers (M13 -20 and M13 reverse
primers; Stratagene) binding to pBC SK and subsequent
Sanger sequencing. To verify the expression of pmrBwild or
pmrBP344L, RNA was extracted from the transformants using
the RNAprep pure cell/bacteria kit (Tiangen, Beijing, China)
and cDNA was obtained using the Primescript RT reagent kit
(Takara, Dalian, China), which was then used as the template
for real-time PCR (RT-PCR). RT-PCR was performed using
LightCycler 96 (Roche, Mannheim, Germany) with a primer
(AAAAGCTGGAGCTCCACCG) binding to the pBC SK vector
and another primer (GCGGCCTTTTTTCTTCTCAA) binding
to pmrB. The 30S ribosomal subunit protein S12-encoding
rpsL gene was used as a control for RT-PCR with the pair of
primers rpsL13_F and rpsL14_F (Cannatelli et al., 2013). MICs
of colistin against transformants were determined using broth
microdilution of CLSI (CLSI, 2017).
TABLE 1 | Characteristics of patients with bloodstream infection due to colistin-resistant hvKP.
Strain Acquisition1 Patient Age Sex Major diseases Date2 Antimicrobial treatment Outcome
KP767 Hospital 1 51 Male Liver cirrhosis, primary peritonitis 2015-12 Piperacillin-tazobactam Recovered
KP925 Community 2 68 Male Liver abscess 2016-05 Panipenem Recovered
KP543 Community 3 52 Male Liver abscess 2017-03 Imipenem plus aztreonam Recovered
KP775 Community 4 72 Male Liver abscess 2017-04 Imipenem Recovered
KP209 Hospital 5 59 Male Pancreatic cancer 2017-06 Imipenem Death
1The strain considered as community acquired if it was recovered from a sample collected within 48 h of hospitalization. Otherwise, the strain was considered hospital
acquired. 2Date refers to when the blood culture that grew colistin-resistant hvKP was collected.
TABLE 2 | Characteristics of colistin-resistant hvKP.
Strain ST (allele no.1) Capsular type Hypermucoviscous Colistin MIC Colistin resistant
mechanism
Antimicrobial
resistance genes
Virulence factors
KP767 660 (2-1-2-1-4-1-25) K16 − 4 PhoQ D150G blaSHV−1, fosA,
oqxA, oqxB
fyuA, iroBCDN, irp2, iucABCD,
iutA, kfuAB, mrkABCDFHIJ,
rmpA, rmpA2, ybtAEPQTUX
KP925 23 (2-1-1-1-9-4-12) K1 − 8 Undefined2 blaSHV−36, fosA,
oqxA, oqxB
allABCDRS, arcC, clbBK, fdrA,
fyuA, gcl, glxKR, hyi, iroBCDN,
irp1, irp2, iucABCD, iutA,
kfuABC, KP1,
mceABCDEGHIJ,
mrkABCDFHIJ, rmpA, rmpA2,
ybbWY, ybtAEPQTUX, ylbEF
KP543 412 (2-1-2-1-9-1-112) K57 + 8 PhoQ D150G blaSHV−11, fosA,
oqxA, oqxB,
iroBCD, mrkABHI, rmpA,
rmpA2
KP775 700 (10-1-17-37-12-1-9) K1 + 16 mcr-1 PhoQ
D150G
aph(4)-Ia,
aac(3)-IVa,
aph(3’)-Ia, aadA1,
aadA2, blaSHV−1,
blaCTX−M−14,
cmlA1, dfrA1,
dfrA12, fosA, fosA,
floR, mcr-1, oqxA,
oqxB, qnrS1, sul1,
sul2, sul3, tet(A)
fyuA, iroBCDN, irp2, iucABCD,
iutA, rmpA, ybtAEPQTUX
KP209 23 (2-1-1-1-9-4-12) K1 + 8 Undefined2 blaSHV−36, oqxA,
oqxB
allABCDRS, arcC, clbBK, fdrA,
fyuA, gcl, glxKR, hyi, iroBCDN,
irp1, irp2, iucABCD, iutA,
kfuABC, KP1,
mceABCDEGHIJ,
mrkABCDFHIJ, rmpA, rmpA2,
ybbWY, ybtAEPQTUX, ylbEF
1Allele order is gapA-infB-mdh-pgi-phoE-rpoB-tonB. 2The two strains did not have any known plasmid-borne colistin-resistance genes (mcr-1 to -5) and any chromosomal
mutations (e.g., mutations/insertions in PhoP-Q, PmrA-B, and MgrB) that are known to confer colistin resistance.
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FIGURE 1 | Alignment of the virulence genes-carrying plasmid pLVPK and
contigs belonged to the colistin-resistant hypervirulent strains. The alignment
was performed using BRIG by aligning the draft genome sequences to pLVPK
(GenBank accession no. AY378100). The locations of virulence genes rmpA,
rmpA2, iucABCD, iutA, and iroBCDN are indicated.
Virulence Assay
The virulence of the strains was assessed using wax moth
(Galleria mellonella) larvae weighing 250 to 350 mg (Tianjin
Huiyude Biotech Company, Tianjin, China). Overnight cultures
of K. pneumoniae strains were washed with phosphate-buffered
saline (PBS) and further adjusted with PBS to concentrations
of 1 × 104 CFU/ml, 1 × 105 CFU/ml, 1 × 106 CFU/ml,
1 × 107 CFU/ml. Sixteen larvae were injected with 10 µl of
inoculum using a 25-µl Hamilton syringe into hemocoel via the
last left proleg (Peleg et al., 2009) and were then incubated at 37◦C
in plastic containers. The number of live larvae was counted every
12 h for 3 days. Two blaKPC−2-carrying carbapenem-resistant
K. pneumoniae clinical isolates of ST11, KP10, and KP13F4, both
of which had no rmpA and rmpA2 genes, were used as the control.
All experiments were performed in triplicate.
RESULTS
Among 112 Klebsiella strains collected from blood during the
study period, five K. pneumoniae strains (Table 1) were found to
be colistin resistant (MIC, 4 to 16 µg/ml; Supplementary Table
S1) and hypervirulent (see below) and were therefore included
in this study. The five K. pneumoniae strains were recovered
from five different male patients with liver abscess, peritonitis
or pancreatic cancer. There was no obvious epidemiological link
among the five patients, as the hospitalization of the patients did
not overlap. Three of the five strains were community acquired
(as determined by days between admission and infection), all of
which were associated with liver abscess, while the remaining two
were hospital acquired and were not associated with liver abscess
(Table 1). Three of the five strains were hypermucoviscous. Two
hypermucoviscous strains belonged to ST23:K1 (Table 1), the
best-known hypervirulent phylogenetic group of K. pneumoniae
commonly associated with community-acquired pyogenic liver
abscess (Brisse et al., 2009). There were 286 SNPs between
the two ST23:K1 strains, suggesting that they did not share a
common transmission event. Another hypermucoviscous strain
was identified as ST700:K1 (Table 1). The remaining two strains
formed mucoid strings < 5 mm though they were mucoid on
agar plates (Table 2) and belonged to ST660:K16 and ST412:K57,
respectively (Table 1). A phylogenetic tree was inferred for the
five strains (Supplementary Figure S1).
All five strains carried rmpA and the salmochelin-encoding
iro cluster plus various combinations of other hypervirulence-
associated genes (Table 2). Neither truncations nor stop codons
were present within the open reading frames of these genes.
The above virulence genes could be plasmid-borne (Brisse et al.,
2009; Holt et al., 2015). Three strains aligned to almost all parts
FIGURE 2 | Survival of G. mellonella after infection by the colistin-resistant hypervirulent strains. The effect of 1 × 106 CFU/ml of each hvKP isolate on survival of
G. mellonella is shown, while those of other inoculums are shown in Supplementary Table S2. KP10 and KP13F4 were two blaKPC−2-carrying
carbapenem-resistant K. pneumoniae clinical isolates of ST11 and were used as the control.
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of pLVPK including the region in which the rmpA, rmpA2,
iucABCD, iutA, and iroBCDN genes were located, while the
remaining two strains (KP543 and KP775) aligned to most parts
of pLVPK except the 16-kb region containing iucABCD/iutA or
rmpA2, respectively (Figure 1).
The 80% lethal dose at 48h of strain KP767, KP925, KP543,
KP775, and KP209 against G. mellonella was 1 × 104, 1 × 104,
1 × 105, 1 × 106, and 1 × 106 CFU/ml, respectively.
Using a bacterial inoculum of 1 × 106 CFU/ml, survival of
G. mellonella at 72 h after infection was 25% with strain
KP209 (hypermucoviscous, ST23:K1) and was 0% with the
remaining four colistin-resistant hvKP strains including two
hypermucoviscous and two non-hypermucoviscous strains, while
survival was 62.5 and 93.8% with the control strains KP10 and
KP13F4, respectively (Figure 2 and Supplementary Table S2).
This suggests that the five colistin-resistant strains were truly
hypervirulent and hypervirulence of K. pneumoniae is not always
associated with the hypermucoviscous phenotype.
Only one (strain KP775) of the five strains carried a
known plasmid-borne colistin resistance gene, mcr-1 (Table 2).
Chromosomal mutations in genes encoding PhoPQ, PmrAB, and
CrrAB two-component systems and mutations or insertions in
mgrB, which encodes a small transmembrane protein can confer
resistance to colistin in K. pneumoniae (Poirel et al., 2017). These
genes were examined in the five strains to identify mutations
and insertions. Three strains had the known colistin-resistant
D150G substitution in PhoQ (Poirel et al., 2017) including the
one carrying mcr-1, while no known colistin-resistant mutations
and insertions were present in the remaining two strains,
KP925 and KP209. However, both KP925 and KP209 had a
C1031T mutation of pmrB, which encodes a P344L substitution
(pmrBP344L). It is unknown whether the P344L substitution of
PmrB could mediate colistin resistance. Cloning of pmrBP344L
into a colistin-susceptible strain and cloning of pmrBwild from
the colistin-susceptible strain into both KP925 and KP209 were
successful and pmrBwild or pmrBP344L was indeed expressed in
TABLE 3 | MICs colistin against of KP9G2, KP925, and KP209 and their
transformants.
Strain pmrB type on
chromosome
pmrB type on
pBC SK
Colistin MIC
(µg/ml)
9G2 Wild 1
9G2 (pBC
SK-pmrBP344L)
Wild P344L 1
KP925 P344L 8
KP925 (pBC SK) P344L 8
KP925 (pBC
SK-pmrBwild)
P344L Wild 8
KP925 (pBC
SK-pmrBP344L)
P344L P344L 8
KP209 P344L 8
KP209 (pBC SK) P344L 8
KP209 (pBC SK-
pmrBwild)
P344L Wild 8
KP209 (pBC
SK-pmrBP344L)
P344L P344L 8
the corresponding transformants. However, the introduction of
pmrBwild or pmrBP344L did not alter MICs of colistin against the
corresponding strains (Table 3).
All five strains were susceptible to amikacin, gentamicin,
ciprofloxacin, piperacillin-tazobactam, imipenem and
tigecycline. Only one strain, KP775, was resistant to ceftriaxone
and sulfamethoxazole-trimethoprim. Consistent with its
resistance phenotype, strain KP775 had the extended-spectrum
β-lactamase gene blaCTX−M−14, sulphonamide-resistance genes
sul1, sul2 and sul3, and trimethoprim-resistance genes dfrA1 and
dfrA12.
DISCUSSION
Galleriamellonella is a well-established model for testing bacterial
virulence (Ramarao et al., 2012). Our virulence assays clearly
suggest that the five colistin-resistant hvKP strains in this
study displayed a hypervirulent phenotype. The combination of
hypervirulence and carbapenem resistance has been increasingly
reported recently (Arena et al., 2017; Du et al., 2018; Feng et al.,
2018; Wong et al., 2018; Yao et al., 2018). However, reports
on the combination of hypervirulence and colistin resistance
remain scarce. Nonetheless, a hvKP strain carrying mcr-1 has
been described (Gu et al., 2016) and colistin resistance can be
developed in vitro from colistin-susceptible hvKP strains (Choi
and Ko, 2015). Recent studies have also found that in addition
to the well known K1 (mainly associated with ST23) and K2
(associated with a few STs such as ST14, ST25, ST65, ST86, ST110,
ST373, ST374, ST375, ST380, ST434, and ST679) (Struve et al.,
2015) types, a few other types such as ST36:K62 (Feng et al.,
2018), ST412:K57 (Liu et al., 2014) and ST420:K20 (Shankar
et al., 2018) can also become hypervirulent. In this study, we
found hvKP strains of a new type, ST660/K16, which expands
the spectrum of hvKP. Among the four sequence types identified
in the present study, ST23 is a common type associated with
liver abscess in East Asia (Liao et al., 2014; Luo et al., 2014;
Lee et al., 2016), while the remaining three STs (ST412, ST660,
and ST700) remain uncommon in clinical infections. ST412 and
ST660 shared five identical alleles out of the seven used for MLST
and appear to belonged to the clonal group 37 (Liu et al., 2014),
which contains ST37, a relatively common type associated with
healthcare associated infections (Illiaquer et al., 2012; Li et al.,
2017). Strains of ST412 have been found causing bloodstream
infections in China (Liu et al., 2014; Ma et al., 2018) and several
ST412 strains ave been recovered from throat and nasal swabs
(the Klebsiella PasteurMLST database5). There are two ST660
strains in the database5, which have been recovered from sputum
in China and human blood in Vietnam, respectively. ST700 is
very different from ST23, ST412, and ST660 with one or two
identical alleles and is also not closely related to any common
types associated with clinical infections such as clonal group 258.
There is only one ST700 strain (from human urine in China in
the database5.
5http://bigsdb.pasteur.fr/
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The five patients received a carbapenem (imipenem or
panipenem) or piperacillin-tazobactam for treatment (Table 1).
Four patients recovered, while one who had pancreatic cancer
died. Although all strains were susceptible to piperacillin-
tazobactam and carbapenems and most patients had favorable
outcomes, it seems inevitable that hvKP strains with resistance
to both carbapenems and colistin will soon emerge, in light of
the presence of plasmid-borne colistin resistance, carbapenem
resistance and hypervirulent factors.
A previous study has found that colistin-resistant mutants
of ST23:K1 K. pneumoniae have reduced virulence compared
to their colistin-susceptible progenitors with one mutation
even losing the hypermucoviscous phenotype (Choi and Ko,
2015). These colistin-resistant mutants have been obtained
via in vitro passages and selection with colistin (Choi and
Ko, 2015). By contrast, the strains in the present study do
not have colistin-susceptible progenitors to compare, as they
were wild strains. Nonetheless, one ST23:K1 strain (KP925)
in the present study was not hypermucoviscous, which is
consistent with the findings of the previous study (Choi and
Ko, 2015). On the other hand, both ST23:K1 still exhibited
hypervirulence in the G. mellonella model. Therefore, we
are unable to confirm the association with colistin resistance
and reduced virulence in the previous study (Choi and
Ko, 2015) due to the absence of the colistin-susceptible
progenitors as control but such an association warrants further
investigations.
Our study suggests that the P344L substitution of PmrB
does not mediate colistin resistance in K. pneumoniae. The
P344L substitution of PmrB has been seen STs other than
ST23 (Pragasam et al., 2016) and not all ST23 strains have
the substitution (Choi and Ko, 2015). Therefore, the colistin
resistance mechanism in strains KP209 and KP925 remains
undetermined. In addition to mutations or insertions in genes
encoding PhoPQ, PmrAB, CrrAB, and MgrB, other mechanisms
such as capsule have been suggested to be associated with colistin
resistance in this species (Formosa et al., 2015). The association
of capsule and colistin resistance in strains KP209 and KP925
therefore warrants further studies.
CONCLUSION
In conclusion, we identified five colistin-resistant hvKP strains
of different clonal backgrounds. Surveillance of colistin-
resistant hvKP strains is urgently required to generate essential
information for preventing their spread.
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